The pharmaceutical industry is facing accelerating AI adoption, advanced biologics expansion, and regulatory shifts reshaping global drug pipelines. From decentralized clinical trials and AI-powered drug discovery to gene and cell therapies, precision medicine, and digital therapeutics, innovation is compressing development timelines while increasing therapeutic complexity.